1997
DOI: 10.1182/blood.v89.8.2909
|View full text |Cite
|
Sign up to set email alerts
|

Monoclonal Antibodies Specific to the Acute Lymphoblastic Leukemia t(1; 19)-Associated E2A/pbx1 Chimeric Protein: Characterization and Diagnostic Utility

Abstract: Nonrandom chromosomal abnormalities are found in most human malignancies, particularly leukemias and lymphomas. A characteristic t(1; 19) (q23; p13.3) chromosomal translocation is detected in 5% of childhood acute lymphoblastic leukemia (ALL) cases. This translocation results in the formation of a fusion gene, which leads to the expression of an oncogenic E2A/pbx1 protein. Breakpoints in the E2A gene almost invariably occur within a single intron, and the identical portion of PBX1 is joined consistently to exo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1999
1999
2021
2021

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 30 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…The translocation results in a chimaeric fusion gene consisting of the transcription activating motif of E2A and the DNA‐binding homeodomain of PBX1 (Hunger et al , 1991; Kamps et al , 1990; Nourse et al , 1990). Polyclonal (Berendes et al , 1995) and monoclonal antibodies (Sang et al , 1997) have been successfully used for the identification of ALL cases carrying this translocation. These could be used for screening cases with failed cytogenetics in which no material is available for molecular analysis.…”
Section: The T(1;19)(q23;p13) Translocation and Detection Of E2a/pmentioning
confidence: 99%
“…The translocation results in a chimaeric fusion gene consisting of the transcription activating motif of E2A and the DNA‐binding homeodomain of PBX1 (Hunger et al , 1991; Kamps et al , 1990; Nourse et al , 1990). Polyclonal (Berendes et al , 1995) and monoclonal antibodies (Sang et al , 1997) have been successfully used for the identification of ALL cases carrying this translocation. These could be used for screening cases with failed cytogenetics in which no material is available for molecular analysis.…”
Section: The T(1;19)(q23;p13) Translocation and Detection Of E2a/pmentioning
confidence: 99%